Director, Investment Manager
Boehringer Ingelheim Venture Fund
Martin joined Boehringer Ingelheim Venture Fund in 2010 in Germany and moved to Boston, MA in 2013 to open US offices for the fund. He serves as board member of Tilos Therapeutics, Sentien Biotechnologies, Abexxa Biologics and Armagen, Inc.. Martin is board observer at Hookipa Pharma, Inc.
Martin is attending / has attended:
Sign up now to stay up-to-date with all our events, news, deals and more!